AstraZeneca's David Brennan - CEO Pay

David Brennan, AstraZeneca CEO

David Brennan - AstraZeneca

Total Compensation: $4.3M

2007 Revenue: $29.55B
2006 Revenue: $26.47B
Change: 11.6%

Details: Brennan made 2.15 million pounds ($4.3 million) in 2007, about $2 million of that as base salary and the rest variable compensation. Though his base was set at 5.5 percent higher in 2007 than 2006, his total package dropped by 19 percent because of smaller bonus and decreased reimbursements for relocation expenses. Overall, his pay fell 19%.

AstraZeneca News:
AstraZeneca's CEO sees 19% pay cut
Analyst: AZ "worst performer" in pharma
AstraZeneca lays out road map for recovery

AstraZeneca's David Brennan - CEO Pay

Suggested Articles

Johnson & Johnson and Bayer’s Xarelto is working to reverse a sales slide, and a new indication could help.

AZ's FluMist will be dramatically limited in the U.S. this flu season because of production problems, a spokeswoman said.

To get its $12 billion opioid deal off the ground, Purdue Pharma pushed for a stay on thousands of lawsuits against it. Last week, a judge signed off.